Thursday, January 30, 2014 3:39:01 AM
Check out the rest of their info. at their website www.anikatherapeutics.com ; IMO everyone should be taking a small position in ANIK over the next few weeks, either through buying the Common or by buying some Call Options;
- Business Overview - Anika develops, manufactures and commercializes therapeutic products for tissue protection, healing, and repair. Its products are based on hyaluronic acid ("HA"), also known as hyaluronan, a naturally occurring biocompatible polymer found in the body.
- Market Cap of about $455,000,000 as at Jan. 29, 2014,
- O/S of ONLY 14,000,000 shares and even lower float, with institutions and insiders holding greater than 65% of the float,
- They had more than $17M in Revenue, $5M in Net Income and more than $64M in cash alone from the quarter ending Sept. 30, 2013; 4Q and Full-Year 2013 earnings will probably be announced during the last week of Feb. 2014,
- Added to the S&P Smallcap 600 at the end of Nov. 2013; it forced institutions holding shares of companies in Biotech Indexes to buy into ANIK, causing the stock to soar from 31 to 38, before settling down to a current 33.
- On the FDA front, they have their flagship FDA-approved Orthovisc for the treatment of osteoarthritis of the knee and various other joints; they are awaiting FDA approval of a single injection version, Monovisc, which decision is due out any day now !! It is currently sold in Europe and Asia; they have a product Cingal, their second single-injection osteoarthritis product under development, is based on hyaluronic acid material with an added active therapeutic molecule designed to provide broad pain relief for a longer period of time. It is currently undergoing clinical trials in the U.S., currently at the patient recruitment stage, with results to be made available later in 2014,
- In addition to the current outstanding staff at the company, in Oct. 2013, Anika Therapeutics appointed John W. Sheets Jr. Ph.D. as its Chief Scientific Officer. Dr. Sheets comes from Boston Scientific, where he was Sr. V.P. of Corporate Research.
=================================================================
Read up on Anika Therapeutics --- do your DD --- and you may find as I did an untappes gem of a company with amazing things on the horizon !!
GLTA !!
Recent ANIK News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2024 09:15:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 08:12:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 08:10:21 PM
- Anika Announces CFO Transition • GlobeNewswire Inc. • 05/08/2024 08:08:54 PM
- Anika Reports First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/08/2024 08:05:17 PM
- Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 05/03/2024 08:01:33 PM
- Anika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024 • GlobeNewswire Inc. • 04/18/2024 08:01:45 PM
- Anika to Participate in the 23rd Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/02/2024 12:00:28 PM
- Anika Reports Fourth Quarter and Year-End 2023 Financial Results • GlobeNewswire Inc. • 03/13/2024 08:05:34 PM
- Mixed Futures Amidst Quiet Economic Schedule; Oil Prices Climb • IH Market News • 03/13/2024 11:03:39 AM
- Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 03/08/2024 09:01:12 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 03/07/2024 12:30:09 AM
- Anika to Issue Fourth Quarter and Year-End 2023 Financial Results on Wednesday, March 13, 2024 • GlobeNewswire Inc. • 02/27/2024 09:01:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2024 02:00:21 PM
- Anika Highlights Its Recently Launched Integrity™ Implant System and RevoMotion™ Reverse Shoulder Arthroplasty System Along with Other Key Regenerative Products During the 2024 AAOS Annual Meeting • GlobeNewswire Inc. • 02/13/2024 02:00:26 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/09/2024 04:09:33 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/24/2024 07:27:19 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 01/22/2024 02:29:20 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/19/2024 09:52:43 PM
- Form 3/A - Initial statement of beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 01/12/2024 09:35:28 PM
- Anika Announces First Surgeries Performed using the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Rotator Cuff Repairs, Commencing Limited Market Release • GlobeNewswire Inc. • 11/28/2023 02:00:43 PM
- Anika to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 11/07/2023 09:05:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/02/2023 08:11:11 PM
- Anika Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance on Growing Momentum Across the Business • GlobeNewswire Inc. • 11/02/2023 08:05:12 PM
- Anika to Issue Third Quarter 2023 Financial Results on Thursday, November 2, 2023 • GlobeNewswire Inc. • 10/10/2023 01:00:07 PM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM